ONC

BeiGene Ltd
D

ONC

319.79
USD
-16.27
(-4.84%)
مغلق
حجم التداول
15,831
الربح لكل سهم
3
العائد الربحي
-
P/E
-189
حجم السوق
35,125,369,999
المقالات

العنوان: BeOne Medicines Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.